Sun Pharma (Netherlands) B.V. 3
3 · Krystal Biotech, Inc. · Filed Sep 19, 2017
Insider Transaction Report
Form 3
Sun Pharma (Netherlands) B.V.
10% Owner
Holdings
- 914,107
Series A Convertible Preferred Stock
Footnotes (1)
- [F1]The Series A convertible preferred stock will automatically convert on a one-to-one basis into 914,107 shares of common stock upon the closing of Krystal Biotech, Inc.'s initial public offering.